Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer

Fertil Steril. 2006 Sep;86(3):588-96. doi: 10.1016/j.fertnstert.2006.02.086. Epub 2006 Jun 30.

Abstract

Objective: To study the value of E(2) production during controlled ovarian hyperstimulation (COH) in predicting IVF-ET outcome.

Design: Historical cohort.

Setting: Academic infertility center.

Patient(s): A cohort of 270 patients who completed 324 consecutive IVF-ET treatment cycles.

Intervention(s): None.

Main outcome measure(s): Area under the curve for E(2) levels (AUC-E(2)) from the first day of COH until the day of hCG administration was calculated and cycles grouped into low, average, and high AUC-E(2) groups. Clinical pregnancy rates per cycle were compared among the three groups, and correlations with AUC-E(2) values were calculated for all patients and after sub-grouping according to age, COH protocol and infertility diagnosis.

Result(s): Cycles with low and high AUC-E(2) values had significantly lower pregnancy rates particularly in patients 35 years or older. There was a positive correlation between AUC-E(2) and pregnancy rates up to a certain AUC-E(2) level above which a negative correlation was found. The turning point between positive and negative correlations occurred at a significantly lower AUC-E(2) level in patients 35 years or older.

Conclusions: Estradiol production during COH correlates with IVF-ET outcome. Women >35 years of age seem more vulnerable to high E(2) levels.

MeSH terms

  • Adult
  • Age Distribution
  • Biomarkers / blood
  • Cohort Studies
  • Embryo Transfer / statistics & numerical data*
  • Estradiol / blood*
  • Female
  • Fertilization in Vitro / statistics & numerical data*
  • Humans
  • Infertility, Female / blood*
  • Infertility, Female / diagnosis
  • Infertility, Female / epidemiology
  • Infertility, Female / therapy*
  • New York / epidemiology
  • Ovulation Induction / statistics & numerical data*
  • Pregnancy
  • Pregnancy Rate*
  • Retrospective Studies
  • Statistics as Topic
  • Treatment Outcome

Substances

  • Biomarkers
  • Estradiol